With an estimated 2.8 million women with a history of breast cancer in the United States and 246,660 new cases of invasive breast cancer to be diagnosed in 2016 alone, there is a very high probability you will be faced with protecting a breast cancer survivor in the future if you haven’t already.
As a result of increased preventative screening – including regularly performed breast self-exams, routine mammograms, discovery of genetic predisposition testing and advancement in treatments – early detection is naturally higher. For that reason, many life insurance carriers have improved underwriting guidelines, leading to decreased postponement periods and more favorable ratings for clients with a history of breast cancer.
The key to successfully insuring your breast cancer survivor is understanding what information is important to enable your underwriting team to find the very best solution.
Additional questions that may help in your assessment:
Additionally, one of the most important pieces of information will be whether or not the client is in full remission/cancer-free and when (month/year). The longer they have been cancer free, with regular follow-up and testing, the more favorable their offer may be.
For life insurance carriers to give consideration of someone who has a history of breast cancer, they must fully complete treatment (surgery, radiation, chemo) and often undergo a specific waiting period referred to as a postponement period (which varies based on stage of breast cancer). If they are past the initial waiting period, and they are taking hormonal therapy, such as Tamoxifen, Arimidex, etc., as part of their treatment plan, there would not be an additional postponement/waiting period for consideration. Everything will still depend on the stage of the breast cancer, type of treatment, and date of last treatment.
Let Ash Brokerage assist you with your next breast cancer case – to simplify your fact-finding process, use our Breast Cancer Client Questionnaire and reach out to us for help. We leverage our experience, carrier relationships and resources to identify viable solutions based on your client’s individual circumstances and insurance needs.
On March 11, 2016, Kristina Alderdice lost her 10-year battle with breast cancer and we lost a sister of our Ash Brokerage Family. Kristina’s legacy lives on in all of our cherished memories and through her mission at Hope in a Handbag . The organization supports mastectomy patients with a necessities bag, which gives supplies and information to aid in their recovery, and also provides a resource for surgeons and nurses to improve communication with patients about the challenges of major surgery. To date, Hope in a Handbag has distributed more than 2,000 bags to women in northeast Indiana.
Julie’s unwavering passion and dedication for risk advocacy promotes lasting partnerships while driving impactful results for all stakeholders, from our agents to our carriers. She leverages her 20 years of industry experience with her relational approach to ensure you experience the Ash difference.
It may be an uncomfortable topic, but you may want to ask your clients if they’ve ever had a colonoscopy. Why? Colonoscopies are important in screening and preventative measure for colorectal cancer.
In the United States, colorectal cancer is the third most commonly diagnosed cancer (excluding skin cancers) and the second leading cause of cancer death in men and women combined. According to the American Cancer Society, in 2016, 134,490 people will be diagnosed and 49,190 people will die from this disease.*
The good news? When it’s discovered early, colorectal cancer is highly treatable. In many cases, regular screening can prevent cancer by finding and removing polyps before they become cancer. And if cancer is already present, earlier detection means a better chance at a longer life.
As we see with many cancers, survival rates for colorectal cancer have been progressively improving since the mid-1980s as a direct result of early detection, routine screening and increased public awareness. Currently there are more than 1 million colorectal cancer survivors in the United States!*
For clients with colorectal cancers, insurability is largely dependent on the age at diagnosis, years since treatment, and other details. Those with early forms of cancer may be insurable with completion of successful treatment within one to two years, while those with more advanced stages could be postponed a full four years or be uninsurable.
When evaluating someone with history of polyps and/or colon cancer, it’s important to know:
With so many variables involved, we’ve created a. No matter the situation, we encourage you to ask questions and get all the facts. Have a specific question? Check out the resources below or drop me a line and we'll be happy to help.
Diane Fulk has been in the life insurance industry for more than 40 years, helping many families secure much needed life insurance coverage and peace of mind. She approaches each case, like each person, individually. She is certified in EKG interpretations, has passed all three of the Academy of Life Insurance Underwriting exams and many LOMA exams.
Cervical cancer may be one of the most treatable and preventable cancers out there, but that doesn’t mean we shouldn’t worry about it. Education is important – not only for prevention and early detection, but also for underwriting.
According to the National Cervical Cancer Coalition (NCCC), each year, an estimated 12,000 women are diagnosed with cervical cancer and one-third will die as a result. So even though the overall risk of cervical cancer has declined over the last few decades, it’s still a serious issue.
The human papillomavirus (HPV) is the most common infection known to cause cell changes on the cervix that can lead to cervical cancer. HPV is the most common sexually transmitted infection in the United States – so common, in fact, nearly all sexually active men and women will get it at some point in their lives, according to the Centers for Disease Control.
When it comes to insurance, your clients’ participation in regular Pap screenings not only helps reduce the risk of advanced cancer, it may also be viewed as a credit during the underwriting process.
Earlier detection and successful treatment rates have also increased the insurability of individuals with a history of cervical cancer. Someone with a low-grade diagnosis can potentially secure a non-rated offer, and someone with a high-grade/early stage diagnosis could qualify for rated offers within a year, and possibly standard rates after three years.
With so many variables involved – from the diagnosis/treatment details to carrier risk assessment – we’ve created a comprehensive questionnaire to assist you in your fact-finding efforts.
No matter the situation, we encourage you to ask questions and get all the facts. Have a specific question? Check out the resources below or drop me a line and we'll be happy to help.
Dianne Leidigh has earned an unwavering reputation, among customers and constituents alike, as a respected partner and trusted resource. Through her personal commitment to continuous professional growth, she’s become an Associate of the Life Management Institute, Associate of Customer Service with LOMA, and an Associate of the Academy of Life Underwriting. As Dianne approaches her second decade in the brokerage life insurance industry, much of which dedicated to advocating risk, her passion for helping others, commitment to personal growth, and perseverance truly yield winning solutions!
© 2018 Ash Brokerage LLC.